Benjamin C. Duncan

Abstract B015: Targeting myeloperoxidase delays pancreatic cancer growth and enhances chemotherapy response

Pancreatic cancer remains one of the deadliest diseases, with fewer than 13% of patients surviving beyond 5 years after diagnosis. Its resistance to current therapies is driven in part by a uniquely immunosuppressive tumor microenvironment, primarily characterized by an extensive infiltration of tumor-associated myel...